FUB-AMB


FUB-AMB (also known as AMB-FUBINACA and MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug. It was originally developed by Pfizer which described the compound in a patent in 2009, but was later abandoned and never tested on humans.

wikipedia

The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

 

product details

 

Category:

Description

FUB-AMB (also known as AMB-FUBINACA and MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug. It was originally developed by Pfizer which described the compound in a patent in 2009, but was later abandoned and never tested on humans.

wikipedia

The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

TYPE: Cannabinoid

POWER: light | normal | strong | very strong

Systematic (IUPAC) name: methyl (2S)-2-{[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino}-3-methylbutanoate
CAS Number: 1715016-76-4
PubChem: 119026173
ChemSpider: 32741679
UNII: TY9AKI870R
Formula: C21H22FN3O3
Molar mass: 383.42 g/mol

Reviews

There are no reviews yet.

Be the first to review “FUB-AMB”
feedback_mix.png